stallimycin has been researched along with Angiogenesis, Pathologic in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vinson, C | 1 |
| Ciomei, M | 2 |
| Pastori, W | 2 |
| Mariani, M | 2 |
| Sola, F | 2 |
| Grandi, M | 3 |
| Mongelli, N | 3 |
| Paio, A | 1 |
| Franzetti, C | 1 |
| Melegaro, G | 1 |
| Biasoli, G | 1 |
| Pesenti, E | 1 |
| Farao, M | 1 |
| Della Torre, P | 1 |
1 review available for stallimycin and Angiogenesis, Pathologic
| Article | Year |
|---|---|
A rationally designed small molecule that inhibits the HIF-1alpha-ARNT heterodimer from binding to DNA in vivo.
Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Aryl Hydrocarbon Receptor Nuclear Translocator; Base | 2005 |
3 other studies available for stallimycin and Angiogenesis, Pathologic
| Article | Year |
|---|---|
New sulfonated distamycin A derivatives with bFGF complexing activity.
Topics: 3T3 Cells; Animals; Binding, Competitive; Distamycins; Fibroblast Growth Factor 2; Mice; Mice, Inbre | 1994 |
In vitro activity of novel sulphonic derivatives of distamycin A.
Topics: 3T3 Cells; Animals; Capillaries; Cell Survival; Distamycins; Doxorubicin; Fibroblast Growth Factor 2 | 1992 |
In vivo activity of novel sulphonic derivatives of distamycin A.
Topics: Animals; Antineoplastic Agents; Collagen; Distamycins; Female; Fibroblast Growth Factor 2; Lymphoma, | 1992 |